Avitar, Inc. (AVTI)

Market Cap	731.00 -99.7%
Revenue (ttm)	2.66M -41.6%
Net Income	-2.80M
EPS	-0.06
Shares Out	731.31M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500
Average Volume	663,147
Open	0.000001
Previous Close	n/a
Day's Range	0.000001 - 0.000001
52-Week Range	0.000001 - 0.000001
Beta	-72.57
RSI	47.38
Earnings Date	n/a

About Avitar

Avitar, Inc., through its subsidiaries, designs, develops, manufactures, and markets diagnostic test products and proprietary hydrophilic polyurethane foam disposables for medical, diagnostics, dental, and consumer applications in the United States. It offers ORALscreen 4 and ORALscreen DRUGOMETER, the oral fluid-based onsite assay systems, for detecting drugs of abuse, such as opiates, including heroin, morphine, codeine, and synthetic opiates comprising oxycocone-oxycontin, percoset, and hydrocodone-vicodin; cocaine, such as crack; marijuana;...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1986
• Employees: 36
• Stock Exchange: OTCMKTS
• Ticker Symbol: AVTI

Financial Performance

In fiscal year 2007, Avitar's revenue was $3.11 million, a decrease of -31.26% compared to the previous year's $4.52 million. Losses were -$2.41 million, -37.61% less than in 2006.